北京大学学报（医学版） ›› 2022, Vol. 54 ›› Issue (5): 814-821. doi: 10.19723/j.issn.1671-167X.2022.05.006
类器官在癌症研究、药物筛选与精准诊疗中的应用进展
张宁*(
),杨慧,王鹏
- 北京大学第一医院肿瘤转化与研究中心，北京 100034
宁 张*(),慧 杨,鹏 王
中图分类号:
- R735.3
| 1 |
Wu C , Li M , Meng H , et al. Analysis of status and countermeasures of cancer incidence and mortality in China[J]. Sci China Life Sci, 2019, 62 (5): 640- 647.
doi: 10.1007/s11427-018-9461-5 |
| 2 |
Li L , Knutsdottir H , Hui K , et al. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity[J]. JCI Insight, 2019, 4 (2): e121490.
doi: 10.1172/jci.insight.121490 |
| 3 |
Gillet JP , Varma S , Gottesman MM . The clinical relevance of cancer cell lines[J]. J Natl Cancer Inst, 2013, 105 (7): 452- 458.
doi: 10.1093/jnci/djt007 |
| 4 |
Byrne AT , Alferez DG , Amant F , et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts[J]. Nat Rev Cancer, 2017, 17 (4): 254- 268.
doi: 10.1038/nrc.2016.140 |
| 5 |
Gao H , Korn JM , Ferretti S , et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response[J]. Nat Med, 2015, 21 (11): 1318- 1325.
doi: 10.1038/nm.3954 |
| 6 |
Sato T , Vries RG , Snippert HJ , et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459 (7244): 262- 265.
doi: 10.1038/nature07935 |
| 7 |
Jacob F , Salinas RD , Zhang DY , et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity[J]. Cell, 2020, 180 (1): 188- 204.
doi: 10.1016/j.cell.2019.11.036 |
| 8 |
Fujii M , Shimokawa M , Date S , et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016, 18 (6): 827- 838.
doi: 10.1016/j.stem.2016.04.003 |
| 9 |
Rosenbluth JM , Schackmann RCJ , Gray GK , et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages[J]. Nat Commun, 2020, 11 (1): 1711.
doi: 10.1038/s41467-020-15548-7 |
| 10 |
Sato T , Stange DE , Ferrante M , et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium[J]. Gastroenterology, 2011, 141 (5): 1762- 1772.
doi: 10.1053/j.gastro.2011.07.050 |
| 11 |
Huch M , Dorrell C , Boj SF , et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration[J]. Nature, 2013, 494 (7436): 247- 250.
doi: 10.1038/nature11826 |
| 12 | Schwarz JS , de Jonge HR , Forrest JN . Value of organoids from comparative epithelia models[J]. Yale J Biol Med, 2015, 88 (4): 367- 374. |
| 13 | Huch M , Gehart H , van Boxtel R , et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160 (1/2): 299- 312. |
| 14 |
Bartfeld S , Bayram T , van de Wetering M , et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology, 2015, 148 (1): 126- 136.
doi: 10.1053/j.gastro.2014.09.042 |
| 15 | Sachs N , de Ligt J , Kopper O , et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018, 172 (1/2): 373- 386. |
| 16 |
Hostiuc S , Rusu MC , Negoi I , et al. The moral status of cerebral organoids[J]. Regen Ther, 2019, 10, 118- 122.
doi: 10.1016/j.reth.2019.02.003 |
| 17 |
Drost J , Clevers H . Organoids in cancer research[J]. Nat Rev Cancer, 2018, 18 (7): 407- 418.
doi: 10.1038/s41568-018-0007-6 |
| 18 |
Broutier L , Andersson-Rolf A , Hindley CJ , et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation[J]. Nat Protoc, 2016, 11 (9): 1724- 1743.
doi: 10.1038/nprot.2016.097 |
| 19 |
Fong ELS , Toh TB , Lin QXX , et al. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer[J]. Biomaterials, 2018, 159, 229- 240.
doi: 10.1016/j.biomaterials.2017.12.026 |
| 20 | Tamai M , Adachi E , Tagawa Y . Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils[J]. Tissue Eng Part A, 2013, 19 (21/22): 2527- 2535. |
| 21 |
Robertson MJ , Soibam B , O'Leary JG , et al. Recellularization of rat liver: an in vitro model for assessing human drug metabolism and liver biology[J]. PLoS One, 2018, 13 (1): e0191892.
doi: 10.1371/journal.pone.0191892 |
| 22 |
Neal JT , Li X , Zhu J , et al. Organoid modeling of the tumor immune microenvironment[J]. Cell, 2018, 175 (7): 1972- 1988.
doi: 10.1016/j.cell.2018.11.021 |
| 23 |
Deng J , Wang ES , Jenkins RW , et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation[J]. Cancer Discov, 2018, 8 (2): 216- 233.
doi: 10.1158/2159-8290.CD-17-0915 |
| 24 |
Dijkstra KK , Cattaneo CM , Weeber F , et al. Generation of tumor-reactive T Cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018, 174 (6): 1586- 1598.
doi: 10.1016/j.cell.2018.07.009 |
| 25 |
Gao D , Vela I , Sboner A , et al. Organoid cultures derived from patients with advanced prostate cancer[J]. Cell, 2014, 159 (1): 176- 187.
doi: 10.1016/j.cell.2014.08.016 |
| 26 |
Barker N , Ridgway RA , van Es JH , et al. Crypt stem cells as the cells-of-origin of intestinal cancer[J]. Nature, 2009, 457 (7229): 608- 611.
doi: 10.1038/nature07602 |
| 27 |
van de Wetering M , Francies HE , Francis JM , et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161 (4): 933- 945.
doi: 10.1016/j.cell.2015.03.053 |
| 28 |
Yan HHN , Siu HC , Law S , et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening[J]. Cell Stem Cell, 2018, 23 (6): 882- 897.
doi: 10.1016/j.stem.2018.09.016 |
| 29 |
Vlachogiannis G , Hedayat S , Vatsiou A , et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018, 359 (6378): 920- 926.
doi: 10.1126/science.aao2774 |
| 30 |
Lee SH , Hu W , Matulay JT , et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer[J]. Cell, 2018, 173 (2): 515- 528.
doi: 10.1016/j.cell.2018.03.017 |
| 31 | Boj SF , Hwang CI , Baker LA , et al. Organoid models of human and mouse ductal pancreatic cancer[J]. Cell, 2015, 160 (1/2): 324- 338. |
| 32 |
Seino T , Kawasaki S , Shimokawa M , et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression[J]. Cell Stem Cell, 2018, 22 (3): 454- 467.
doi: 10.1016/j.stem.2017.12.009 |
| 33 |
Kopper O , de Witte CJ , Lohmussaar K , et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity[J]. Nat Med, 2019, 25 (5): 838- 849.
doi: 10.1038/s41591-019-0422-6 |
| 34 |
Lapointe S , Perry A , Butowski NA . Primary brain tumours in adults[J]. Lancet, 2018, 392 (10145): 432- 446.
doi: 10.1016/S0140-6736(18)30990-5 |
| 35 |
Broutier L , Mastrogiovanni G , Verstegen MM , et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med, 2017, 23 (12): 1424- 1435.
doi: 10.1038/nm.4438 |
| 36 |
Nuciforo S , Fofana I , Matter MS , et al. Organoid models of human liver cancers derived from tumor needle biopsies[J]. Cell Rep, 2018, 24 (5): 1363- 1376.
doi: 10.1016/j.celrep.2018.07.001 |
| 37 |
Zhao Y , Li ZX , Zhu YJ , et al. Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids[J]. Adv Sci (Weinh), 2021, 8 (11): e2003897.
doi: 10.1002/advs.202003897 |
| 38 | Yuan B , Zhao X , Wang X , et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening[J]. Clin Transl Med, 2022, 12 (1): e678. |
| 39 |
Huang L , Holtzinger A , Jagan I , et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids[J]. Nat Med, 2015, 21 (11): 1364- 1371.
doi: 10.1038/nm.3973 |
| 40 |
Matano M , Date S , Shimokawa M , et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids[J]. Nat Med, 2015, 21 (3): 256- 262.
doi: 10.1038/nm.3802 |
| 41 |
Drost J , van Jaarsveld RH , Ponsioen B , et al. Sequential cancer mutations in cultured human intestinal stem cells[J]. Nature, 2015, 521 (7550): 43- 47.
doi: 10.1038/nature14415 |
| 42 |
Sun L , Wang Y , Cen J , et al. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes[J]. Nat Cell Biol, 2019, 21 (8): 1015- 1026.
doi: 10.1038/s41556-019-0359-5 |
| 43 |
Skardal A , Shupe T , Atala A . Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling[J]. Drug Discov Today, 2016, 21 (9): 1399- 1411.
doi: 10.1016/j.drudis.2016.07.003 |
| 44 |
Uchino S , Kellum JA , Bellomo R , et al. Acute renal failure in critically ill patients: a multinational, multicenter study[J]. JAMA, 2005, 294 (7): 813- 818.
doi: 10.1001/jama.294.7.813 |
| 45 |
Morizane R , Lam AQ , Freedman BS , et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury[J]. Nat Biotechnol, 2015, 33 (11): 1193- 1200.
doi: 10.1038/nbt.3392 |
| 46 |
Eder A , Vollert I , Hansen A , et al. Human engineered heart tissue as a model system for drug testing[J]. Adv Drug Deliv Rev, 2016, 96, 214- 224.
doi: 10.1016/j.addr.2015.05.010 |
| 47 | Voges HK , Mills RJ , Elliott DA , et al. Development of a human cardiac organoid injury model reveals innate regenerative potential[J]. Deve-lopment, 2017, 144 (6): 1118- 1127. |
| 48 |
Lancaster MA , Renner M , Martin CA , et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501 (7467): 373- 379.
doi: 10.1038/nature12517 |
| 49 |
Gjorevski N , Sachs N , Manfrin A , et al. Designer matrices for intestinal stem cell and organoid culture[J]. Nature, 2016, 539 (7630): 560- 564.
doi: 10.1038/nature20168 |
| 50 |
Tuveson D , Clevers H . Cancer modeling meets human organoid technology[J]. Science, 2019, 364 (6444): 952- 955.
doi: 10.1126/science.aaw6985 |
| [1] | 赖玉梅,李忠武,李欢,吴艳,时云飞,周立新,楼雨彤,崔传亮. 68例肛管直肠黏膜黑色素瘤临床病理特征及预后[J]. 北京大学学报（医学版）, 2023, 55(2): 262-269. |
| [2] | 王文鹏,王捷夫,胡均,王俊锋,刘嘉,孔大陆,李健. 结直肠间质瘤临床病理特征及预后分析[J]. 北京大学学报（医学版）, 2020, 52(2): 353-361. |
| [3] | 王骁,李兆星,范焕芳,魏莉瑛,郭旭瑾,郭娜,王彤. 罕见小肠囊腺瘤1例报道[J]. 北京大学学报（医学版）, 2020, 52(2): 382-384. |
| [4] | 张威,叶颖江,任仙文,黄晶,申占龙. 利用转录组二代测序探索直肠癌术前放化疗的敏感性分子特征[J]. 北京大学学报（医学版）, 2019, 51(3): 542-547. |
| [5] | 陈贺凯，戴芸，吴婷，汪欣，万远廉，汤坚强. 结肠癌细胞中组织因子/活性凝血因子Ⅶ-表皮生长因子受体通路间交互作用机制[J]. 北京大学学报(医学版), 2017, 49(6): 931-936. |
| [6] | 赵轶国，杨晓东，张雁凯，宁宁，邢兆东，叶颖江. 美克尔憩室癌变及肝多发转移并消化道出血1例[J]. 北京大学学报(医学版), 2017, 49(6): 1095-1097. |
| [7] | 陈杨，王艳荣，石燕，戴广海. 晚期结直肠癌患者一线应用FOLFOX方案化疗引起中性粒细胞减少的预后价值[J]. 北京大学学报(医学版), 2017, 49(4): 669-674. |
|
